United States Federal Circuit
Boston Scientific Corp. v. Johnson & Johnson, 2010-1230
In a patent infringement dispute involving drug-eluting coronary stents, summary judgment on the ground that defendant’s claimed patents are invalid, 35 U.S.C. Section 112, is affirmed where no finder of fact could reasonably determine that the asserted claimed patents contained adequate written description.
Appellate Information
- Decided 06/07/2011
- Published 06/07/2011
Judges
- MOORE
Court
- United States Federal Circuit